Craspase is a CRISPR RNA-guided, RNA-activated protease
- Department of Molecular Biology and Genetics, Cornell University, Ithaca, NY 14853, USA.
- Department of Bionanoscience, Delft University of Technology, 2629 HZ Delft, Netherlands.; Kavli Institute of Nanoscience, 2629 HZ Delft, Netherlands.
- Department of Life Sciences, Pohang University of Science and Technology, Pohang, Gyeongbuk 37673, Republic of Korea.
- Department of Environmental Biotechnology, Delft University of Technology, 2629 HZ Delft, Netherlands.
The CRISPR-Cas type III-E RNA-targeting effector complex gRAMP/Cas7-11 is associated with a caspase-like protein (TPR-CHAT/Csx29) to form Craspase (CRISPR-guided caspase). Here, we use cryo–electron microscopy snapshots of Craspase to explain its target RNA cleavage and protease activation mechanisms. Target-guide pairing extending into the 5' region of the guide RNA displaces a gating loop in gRAMP, which triggers an extensive conformational relay that allosterically aligns the protease catalytic dyad and opens an amino acid side-chain–binding pocket. We further define Csx30 as the endogenous protein substrate that is site-specifically proteolyzed by RNA-activated Craspase. This protease activity is switched off by target RNA cleavage by gRAMP and is not activated by RNA targets containing a matching protospacer flanking sequence. We thus conclude that Craspase is a target RNA–activated protease with self-regulatory capacity.
- Research Organization:
- Brookhaven National Laboratory (BNL), Upton, NY (United States). Laboratory for BioMolecular Structure (LBMS)
- Sponsoring Organization:
- USDOE Office of Science (SC)
- DOE Contract Number:
- SC0012704
- OSTI ID:
- 1982963
- Journal Information:
- Science, Vol. 377, Issue 6612; ISSN 0036-8075
- Publisher:
- AAAS
- Country of Publication:
- United States
- Language:
- English
Similar Records
Coupling of ssRNA cleavage with DNase activity in type III-A CRISPR-Csm revealed by cryo-EM and biochemistry
Protospacer Adjacent Motif-Induced Allostery Activates CRISPR-Cas9